Gene A, upregulated by mutant KRAS, is a potential therapeutic target for lung cancer

被引：0
|
作者：
Kawabe, Nozomi [1 ]
Muraki, Nao [1 ]
Tanaka, Ichidai [2 ]
Sunaga, Noriaki [3 ]
Sato, Mitsuo [1 ]
机构：
[1] Nagoya Univ, Dept Integrated Hlth Sci, Nagoya, Aichi, Japan
[2] Nagoya Univ, Grad Sch Med, Dept Resp Med, Nagoya, Aichi, Japan
[3] Gunma Univ, Grad Sch Med, Dept Resp Med, Maebashi, Gumma, Japan
来源：
CANCER SCIENCE | 2024年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E-3031
引用
收藏
页码：1547 / 1547
页数：1
相关论文
共 50 条
  • [1] Fatty Acid Synthase Is a Therapeutic Target in Mutant KRAS Lung Cancer
    Bartolacci, C.
    Padanad, M.
    Andreani, C.
    Melegari, M.
    Rindhe, S.
    George, K.
    Frankel, A.
    McDonald, J.
    Scaglioni, P. P.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (08) : S1538 - S1538
  • [2] KRAS mutant lung cancer: progress thus far on an elusive therapeutic target
    Bhattacharya, Saveri
    Socinski, Mark A.
    Burns, Timothy F.
    CLINICAL AND TRANSLATIONAL MEDICINE, 2015, 4
  • [3] A long non-cording RNA LINC X, induced by the mutant KRAS, is a potential therapeutic target for lung cancer
    Kawabe, Nozomi
    Muraki, Nao
    Komeda, Kazuki
    Ohashi, Ayano
    Umeda, Kanna
    Katsuda, Masahito
    Tomatsu, Aya
    Yoshida, Mikina
    Minna, John
    Tanaka, Ichidai
    Morise, Masahiro
    Matsushima, Miyoko
    Kawabe, Tsutomu
    Sato, Mitsuo
    RESPIROLOGY, 2024, 29 : 90 - 91
  • [4] Targeting IL22: a potential therapeutic approach for Kras mutant lung cancer?
    Weinberg, Frank D.
    Ramnath, Nithya
    TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 : S243 - S247
  • [5] Effectors and potential targets selectively upregulated in human KRAS-mutant lung adenocarcinomas
    Li, Jinyu
    Sordella, Raffaella
    Powers, Scott
    SCIENTIFIC REPORTS, 2016, 6
  • [6] Effectors and potential targets selectively upregulated in human KRAS-mutant lung adenocarcinomas
    Jinyu Li
    Raffaella Sordella
    Scott Powers
    Scientific Reports, 6
  • [7] Gene A, a gene increased by mutant KRAS, is a potentially druggable target for lung adenocarcinoma
    Umeda, Kanna
    Kawabe, Nozomi
    Muraki, Nao
    Komeda, Kazuki
    Ohashi, Ayano
    Katsuda, Masahito
    Tomatsu, Aya
    Yoshida, Mikina
    Minna, John
    Tanaka, Ichidai
    Morise, Masahiro
    Matsushima, Miyoko
    Kawabe, Tsutomu
    Sato, Mitsuo
    RESPIROLOGY, 2024, 29 : 91 - 91
  • [8] KRAS Mutant Lung Cancer
    Janne, P.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S92 - S93
  • [9] Knockdown of Gene A, upregulated by mutant KRAS, inhibits growth of lung cancer in part through upregulating p21
    Kawabe, Nozomi
    Muraki, Nao
    Umeda, Kanna
    Komeda, Kazuki
    Ohashi, Ayano
    Katsuda, Masahito
    Tomatsu, Aya
    Yoshida, Mikina
    Iwabe, Ayana
    Sunaga, Noriaki
    Taguchi, Ayumu
    John, Minna
    Tanaka, Ichidai
    Matsushima, Miyoko
    Kawabe, Tsutomu
    Sato, Mitsuo
    CANCER SCIENCE, 2025, 116 : 903 - 903
  • [10] IKKβ is a potential anti-angiogenic therapeutic target in KRAS-induced lung cancer
    Lobo, Tatiana C.
    Magalhaes, Leila
    Cardeal, Laura
    Giordano, Ricardo
    Baldwin, Albert
    Basseres, Daniela
    CANCER RESEARCH, 2015, 75
12345